ASX - By Stock
|
APX |
Re:
Ann: Update on 1H 22 results and FY2022 outlook
|
|
delivercn
|
626 |
214K |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
626
|
214K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
My Analysis: No synergy value in valuation
|
|
delivercn
|
200 |
43K |
7 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
200
|
43K
|
7
|
|
ASX - By Stock
|
APX |
Re:
Ann: Update on 1H 22 results and FY2022 outlook
|
|
delivercn
|
626 |
214K |
1 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
626
|
214K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Is this the start of the auction?
|
|
delivercn
|
60 |
19K |
19 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
60
|
19K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Offer Increase 21c Vote Yes
|
|
delivercn
|
252 |
72K |
2 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
252
|
72K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Is this the start of the auction?
|
|
delivercn
|
60 |
19K |
7 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
60
|
19K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Is this the start of the auction?
|
|
delivercn
|
60 |
19K |
8 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
60
|
19K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Entry into amended and restated Scheme Implementation Deed
|
|
delivercn
|
104 |
30K |
35 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
104
|
30K
|
35
|
|
ASX - By Stock
|
RAP |
Re:
Offer Increase 21c Vote Yes
|
|
delivercn
|
252 |
72K |
22 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
252
|
72K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
No-vote letter update
|
|
delivercn
|
285 |
75K |
18 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
285
|
75K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
delivercn
|
466 |
161K |
9 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
466
|
161K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
delivercn
|
466 |
161K |
6 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
466
|
161K
|
6
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Clinical trial recruitment completed for US enteric kit
|
|
delivercn
|
3 |
1.4K |
1 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
29 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
446
|
98K
|
29
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
18 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
446
|
98K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
11 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
446
|
98K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
delivercn
|
41 |
10K |
15 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
41
|
10K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
8 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
446
|
98K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
8 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
446
|
98K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
3 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
446
|
98K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
8 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
446
|
98K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
delivercn
|
446 |
98K |
12 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
446
|
98K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Study shows efficacy of ResAppDx use with masks
|
|
delivercn
|
12 |
4.4K |
18 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
12
|
4.4K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
delivercn
|
151 |
45K |
4 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
151
|
45K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
delivercn
|
151 |
45K |
5 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
151
|
45K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
delivercn
|
151 |
45K |
5 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
151
|
45K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
delivercn
|
123 |
36K |
17 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
123
|
36K
|
17
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
delivercn
|
151 |
45K |
9 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
151
|
45K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
NO - Vote Afterlife
|
|
delivercn
|
24 |
8.1K |
6 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
24
|
8.1K
|
6
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Genetic Signatures completes $35m placement
|
|
delivercn
|
12 |
6.3K |
2 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
12
|
6.3K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
NO - Vote Afterlife
|
|
delivercn
|
24 |
8.1K |
14 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
24
|
8.1K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
delivercn
|
151 |
45K |
18 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
151
|
45K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
delivercn
|
151 |
45K |
26 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
151
|
45K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
NO - Vote Afterlife
|
|
delivercn
|
24 |
8.1K |
22 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
24
|
8.1K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of First Court Hearing
|
|
delivercn
|
44 |
17K |
21 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
44
|
17K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of First Court Hearing
|
|
delivercn
|
44 |
17K |
11 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
44
|
17K
|
11
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Genetic Signatures completes $35m placement
|
|
delivercn
|
12 |
6.3K |
0 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
12
|
6.3K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Genetic Signatures completes $35m placement
|
|
delivercn
|
12 |
6.3K |
0 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
12
|
6.3K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of First Court Hearing
|
|
delivercn
|
44 |
17K |
32 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
44
|
17K
|
32
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
delivercn
|
151 |
50K |
4 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
151
|
50K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
VOTING
|
|
delivercn
|
6 |
2.4K |
13 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
6
|
2.4K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Computershare Calling - Pfizer feedback
|
|
delivercn
|
96 |
34K |
11 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
96
|
34K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
delivercn
|
151 |
50K |
2 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
151
|
50K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
delivercn
|
151 |
50K |
1 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
151
|
50K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate Licence Agreement Clarification Announcement
|
|
delivercn
|
34 |
12K |
14 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
34
|
12K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
delivercn
|
132 |
46K |
30 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
132
|
46K
|
30
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
delivercn
|
126 |
37K |
27 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
126
|
37K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
delivercn
|
126 |
37K |
33 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
126
|
37K
|
33
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
delivercn
|
151 |
50K |
14 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
151
|
50K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
delivercn
|
151 |
50K |
7 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
50K
|
7
|
|